Federated Hermes
ACER

Federated Hermes’s Acer Therapeutics Inc ACER Stock Holding History

Federated Hermes’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-114,091
Closed -$299K – 2378
2020
Q4 		$299K Sell
114,091
-3,582
-3% -$9.64K ﹤0.01% 1636
2020
Q3 		$339K Sell
117,673
-28,424
-19% -$91.9K ﹤0.01% 1570
2020
Q2 		$501K Buy
146,097
+56,327
+63% +$159K ﹤0.01% 1479
2020
Q1 		$179K Buy
89,770
+25,176
+39% +$92.2K ﹤0.01% 1591
2019
Q4 		$259K Buy
64,594
+61,377
+1,908% +$209K ﹤0.01% 1565
2019
Q3 		$10K Buy
+3,217
New +$9.43K ﹤0.01% 1890

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Federated Hermes's ACER Position: Q1 2021 in Review

Federated Hermes sold out of Acer Therapeutics Inc (ACER) in Q1 2021, closing a stake of 114,091 shares — an estimated $299K sold.

Federated Hermes first reported a position in ACER in Q3 2019 and held it in 6 quarters. The position peaked at $501K in Q2 2020. 30 funds tracked by Wall St. Rank hold ACER as of Q1 2021.

  • Federated Hermes reported no remaining Acer Therapeutics Inc position as of Q1 2021 after selling out during the quarter.
  • Federated Hermes sold 114,091 Acer Therapeutics Inc shares in Q1 2021, an estimated $299K.
  • Federated Hermes first reported a position in Acer Therapeutics Inc in Q3 2019 and held it in 6 quarters.
  • Federated Hermes's Acer Therapeutics Inc position peaked at $501K in Q2 2020.
  • 30 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q1 2021.

Based on Federated Hermes's 13F filing for Q1 2021, filed 13 May 2021.